title: Radiotherapy-induced skin reactions: assessment and management.
abstract: Radiotherapy, the use of high-energy rays to either kill cancer cells or treat some benign tumours, is undoubtedly a positive intervention. However, as the primary mode of action in radiotherapy treatment is the killing of cells to prevent replication, other non-cancerous cells may be affected. For example, up to 85% of patients will experience some form of skin reaction, which will range from local erythema to moist desquamation. Such reactions are not only distressing and painful for the patient, if severe enough, they may warrant a halt in treatment. This article outlines the aims and nature of radiotherapy, and then discusses the aetiology of skin reactions, risk factors for reaction, and assessment tools. Management interventions will also be shown, with emphasis on silicone dressings.
authors.affiliation: Independent Medical Editor and Writer, London.
authors.forename: Deborah
authors.initials: D
authors.lastname: Glover
authors.affiliation: Team Leader/Clinical Nurse Specialist, Breast Care Unit, Imperial College Healthcare Trust, London.
authors.forename: Victoria
authors.initials: V
authors.lastname: Harmer
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001458:Bandages; D004890:Erythema / Q000188:drug therapy / Q000209:etiology* / Q000451:nursing*; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000532:radiotherapy*; D059408:Pain Management / Q000379:methods; D017410:Practice Guidelines as Topic; D011855:Radiodermatitis / Q000188:drug therapy / Q000209:etiology* / Q000451:nursing*; D011878:Radiotherapy / Q000009:adverse effects*; D012307:Risk Factors; D014945:Wound Healing / Q000187:drug effects
chemical_list: D000305:Adrenal Cortex Hormones